Header Logo

Connection

David Bennett to Mice, Transgenic

Back to Details
This is a "connection" page, showing publications David Bennett has written about Mice, Transgenic.
David Bennett
Connection Strength
0.970
Mice, Transgenic
  1. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.048
  2. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.048
  3. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies. Neurobiol Dis. 2021 12; 161:105542.
    View in: PubMed
    Score: 0.046
  4. Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice. Acta Neuropathol Commun. 2021 07 27; 9(1):129.
    View in: PubMed
    Score: 0.045
  5. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease. Nat Neurosci. 2021 06; 24(6):786-798.
    View in: PubMed
    Score: 0.045
  6. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2021 04 16; 16(1):26.
    View in: PubMed
    Score: 0.045
  7. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.041
  8. Regulation of lifespan by neural excitation and REST. Nature. 2019 10; 574(7778):359-364.
    View in: PubMed
    Score: 0.040
  9. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019; 2:360.
    View in: PubMed
    Score: 0.040
  10. Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects. Sci Rep. 2018 09 03; 8(1):13119.
    View in: PubMed
    Score: 0.037
  11. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology. J Clin Invest. 2018 10 01; 128(10):4297-4312.
    View in: PubMed
    Score: 0.037
  12. A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci. 2018 01 31; 38(5):1085-1099.
    View in: PubMed
    Score: 0.035
  13. Selective lowering of synapsins induced by oligomeric a-synuclein exacerbates memory deficits. Proc Natl Acad Sci U S A. 2017 06 06; 114(23):E4648-E4657.
    View in: PubMed
    Score: 0.034
  14. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener. 2017 03 20; 12(1):26.
    View in: PubMed
    Score: 0.034
  15. Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci. 2016 09 14; 36(37):9647-58.
    View in: PubMed
    Score: 0.032
  16. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol. 2016 06; 14(6):e1002472.
    View in: PubMed
    Score: 0.032
  17. Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense?oligonucleotides. EMBO Mol Med. 2016 04 01; 8(4):328-45.
    View in: PubMed
    Score: 0.031
  18. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
    View in: PubMed
    Score: 0.031
  19. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains. Mol Neurobiol. 2016 10; 53(8):5066-78.
    View in: PubMed
    Score: 0.030
  20. Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(2):385-402.
    View in: PubMed
    Score: 0.029
  21. Life extension factor klotho enhances cognition. Cell Rep. 2014 May 22; 7(4):1065-76.
    View in: PubMed
    Score: 0.028
  22. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr; 254:78-89.
    View in: PubMed
    Score: 0.027
  23. Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment. Cell Death Differ. 2014 May; 21(5):696-706.
    View in: PubMed
    Score: 0.027
  24. PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and A?. J Neurosci. 2013 Jun 26; 33(26):10729-40.
    View in: PubMed
    Score: 0.026
  25. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.025
  26. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.024
  27. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009 Jan; 68(1):48-58.
    View in: PubMed
    Score: 0.019
  28. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron. 2008 Dec 26; 60(6):988-1009.
    View in: PubMed
    Score: 0.019
  29. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging. 2006 Nov; 27(11):1644-57.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.